SarcopeniaEvidence & Dosage
Age-related muscle loss — strength training + protein are the best prevention.
Evidence at a glance
- Total studies
- 1,000
- With abstract
- 46
- Meta / Systematic / RCT
- 2
- Highly cited
- 15
- Publication years
- 1991–2026
Sarcopenia in the context of Longevity
This topic is part of our "Longevity" world. There you'll find methodology, evidence and the highest-impact levers — plus the order in which they sensibly build on each other.
Go to LongevityTop studies on Sarcopenia
Ranked by influential-citation count and publication year.
Epidemiology of sarcopenia among the elderly in New Mexico.
American journal of epidemiology1998n=199200 influential citationsMuscle mass decreases with age, leading to "sarcopenia," or low relative muscle mass, in elderly people. Sarcopenia is believed to be associated with metabolic, physiologic, and functional impairments and disability. Methods of estimating…
Epidemiology of sarcopenia: Prevalence, risk factors, and consequences.
Metabolism: clinical and experimental2023200 influential citationsSarcopenia is a geriatric condition featured by a progressive loss of muscle mass and function and associated with various adverse health outcomes. In this review, we aimed to summarize the epidemiological features of sarcopenia as well as…
Osteosarcopenia: epidemiology, diagnosis, and treatment-facts and numbers.
J Cachexia Sarcopenia Muscle2020n=235other200 influential citationsBACKGROUND: Osteosarcopenia, the presence of osteopenia/osteoporosis and sarcopenia, is an emerging geriatric giant, which poses a serious global health burden. METHODS AND RESULTS: The prevalence of osteosarcopenia ranges in…
Health outcomes of sarcopenia: a consensus report by the outcome working group of the Global Leadership Initiative in Sarcopenia (GLIS).
Aging clinical and experimental research2025200 influential citationsThe Global Leadership Initiative in Sarcopenia (GLIS) aims to standardize the definition and diagnostic criteria for sarcopenia into one unifying, common classification. Among other actions to achieve this objective, the GLIS has organized…
Diagnostic Criteria and Measurement Techniques of Sarcopenia: A Critical Evaluation of the Up-to-Date Evidence.
Nutrients2024Review183 influential citationsSarcopenia, a geriatric syndrome characterized by progressive skeletal muscle mass and function decline, poses a significant health risk among the elderly, contributing to frailty, falls, hospitalization, loss of independence and…
From mitochondria to sarcopenia: role of 17β-estradiol and testosterone.
Front Endocrinol (Lausanne)2023Review58 influential citationsSarcopenia, characterized by a loss of muscle mass and strength with aging, is prevalent in older adults. Although the exact mechanisms underlying sarcopenia are not fully understood, evidence suggests that the loss of mitochondrial…
Creatine supplementation for older adults: Focus on sarcopenia, osteoporosis, frailty and Cachexia.
Bone2022review51 influential citationsSarcopenia refers to the age-related reduction in strength, muscle mass and functionality which increases the risk for falls, injuries and fractures. Sarcopenia is associated with other age-related conditions such as osteoporosis, frailty…
Defining sarcopenia: some caveats and challenges.
Curr Opin Clin Nutr Metab Care2020Review47 influential citationsPURPOSE OF REVIEW: To summarize the latest advances and caveats in defining sarcopenia and discuss the implications of the most recent worldwide initiatives which are trying to harmonize the definition. RECENT FINDINGS: The evolution over…
Nutritional strategies for improving sarcopenia outcomes in older adults: A narrative review.
Pharmacol Res Perspect2024review46 influential citationsSarcopenia is characterized by a decline in muscle strength, generalized loss of skeletal muscle mass, and impaired physical performance, which are common outcomes used to screen, diagnose, and determine severity of sarcopenia in older…
Sarcopenia--mechanisms and treatments.
J Geriatr Phys Ther2009review25 influential citationsBACKGROUND: Sarcopenia is a consequence of aging. This atrophic event is responsible for decrease in strength and associated functional deficits seen in the aging adult. PURPOSE: This paper reviews: (1) the mechanisms contributing to…
Frequently asked
What dosage was studied?
Which population does the evidence apply to?
Are there safety considerations for Sarcopenia?
More topics in Longevity
Zone 2 Training
Low-intensity cardio — mitochondrial biogenesis, a longevity foundation.
Rapamycin
mTOR inhibition, longevity studies, off‑label dosing, and safety.
AMPK Activators
Berberine, alpha‑lipoic acid, energetic stress, and glucose modulation.
ApoB
A better cardiovascular risk metric than LDL-C — modern lipidology.
Autophagy
Cellular self-clearance — fasting, exercise, spermidine as triggers.
Berberin
Glucose, lipids, AMPK and GI tolerability data
Biological Age
GrimAge, PhenoAge, DunedinPACE — what epigenetic clocks measure.
Caloric Restriction
CR mimetics, lifespan research, and NHP studies.
Cancer Screening
Recommendations, overdiagnosis, Galleri tests, whole-body MRI (a critical look).
Cellular Senescence
"Zombie cells," SASP, senolytic approaches.
Collagen
Skin, joints, tendons — evidence favors hydrolysate plus vitamin C.
Dementia Prevention
Lifestyle factors: exercise, sleep, hearing health, vascular health.
DEXA Bone Density
DEXA scan for bone + body composition — the trend matters more than a single value.
Epigenetic Clocks
Horvath, GrimAge, PhenoAge — what they measure and what they don't.
Epigenetics
DNA methylation, histone modifications, environmental influences on gene expression.
Exosomes
Cell-to-cell communication, regenerative applications, an early research field.
Genetic Tests
Variants, pharmacogenomics, limitations — methylation, MTHFR myths.
Glucosamine
Joints, UK Biobank mortality study, sulfate vs HCl forms.
Glycine
Methylation, collagen synthesis, lifespan signals in animal models.
Grip Strength
A strong mortality predictor — easy to measure, trainable.
Related topics from other worlds
Burnout Early Signs
Exhaustion, cynicism, dropping performance — spotting it before the crash.
Doomscrolling
Algorithm-driven negative info consumption — mood effects, limits.
L-Tryptophan
Serotonin/Melatonin, amino‑acid competition and outcomes.
Parasympathetic NS
Rest-and-digest, the vagus nerve, recovery and digestion.
Smartphone Addiction
Behavioral addiction, dopamine loops, detox strategies.
Vagus Nerve Stimulation
Breathing, HRV, transcutaneous stimulation, and anxiety.